These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 24315438)
1. Oversight for clinical uses of autologous adult stem cells: lessons from international regulations. Lysaght T; Kerridge I; Sipp D; Porter G; Capps BJ Cell Stem Cell; 2013 Dec; 13(6):647-51. PubMed ID: 24315438 [TBL] [Abstract][Full Text] [Related]
2. Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations. Lysaght T; Kerridge IH; Sipp D; Porter G; Capps BJ J Bioeth Inq; 2017 Jun; 14(2):261-273. PubMed ID: 28247202 [TBL] [Abstract][Full Text] [Related]
3. Broadening the scope of debates around stem cell research. Lysaght T; Campbell AV Bioethics; 2013 Jun; 27(5):251-6. PubMed ID: 22500617 [TBL] [Abstract][Full Text] [Related]
4. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Bartunek J; Dimmeler S; Drexler H; Fernández-Avilés F; Galinanes M; Janssens S; Martin J; Mathur A; Menasche P; Priori S; Strauer B; Tendera M; Wijns W; Zeiher A; Eur Heart J; 2006 Jun; 27(11):1338-40. PubMed ID: 16543252 [TBL] [Abstract][Full Text] [Related]
9. FDA regulation of adult stem cell therapies as used in sports medicine. Chirba MA; Sweetapple B; Hannon CP; Anderson JA J Knee Surg; 2015 Feb; 28(1):55-62. PubMed ID: 25603042 [TBL] [Abstract][Full Text] [Related]
10. Stem cell research in cell transplantation: sources, geopolitical influence, and transplantation. Eve DJ; Fillmore RW; Borlongan CV; Sanberg PR Cell Transplant; 2010; 19(11):1493-509. PubMed ID: 21054954 [TBL] [Abstract][Full Text] [Related]
11. Jordan's stem-cell law can guide the Middle East. Dajani R Nature; 2014 Jun; 510(7504):189. PubMed ID: 24919888 [No Abstract] [Full Text] [Related]
12. Regulatory loophole enables unproven autologous cell therapies to thrive in Australia. Munsie M; Pera M Stem Cells Dev; 2014 Dec; 23 Suppl 1():34-8. PubMed ID: 25457959 [TBL] [Abstract][Full Text] [Related]
13. The clinician-scientist: professional dynamics in clinical stem cell research. Wilson-Kovacs DM; Hauskeller C Sociol Health Illn; 2012 May; 34(4):497-512. PubMed ID: 21883291 [TBL] [Abstract][Full Text] [Related]
14. US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions. Turner LG Regen Med; 2015 May; 10(4):397-402. PubMed ID: 26022761 [No Abstract] [Full Text] [Related]
15. The current landscape of adipose-derived stem cells in clinical applications. Lim MH; Ong WK; Sugii S Expert Rev Mol Med; 2014 May; 16():e8. PubMed ID: 24807467 [TBL] [Abstract][Full Text] [Related]
16. A regulatory patchwork--human ES cell research oversight. Knowles LP Nat Biotechnol; 2004 Feb; 22(2):157-63. PubMed ID: 14755285 [No Abstract] [Full Text] [Related]
17. Texas stem cell rules may impede clinical research. Arnold C Lancet; 2012 May; 379(9828):1776. PubMed ID: 22586718 [No Abstract] [Full Text] [Related]
18. [Report of the Central Ethics Committee for Stem Cell Research (ZES)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Jul; 56(7):985-91. PubMed ID: 23807406 [No Abstract] [Full Text] [Related]
19. Challenges in the Regulation of Autologous Stem Cell Interventions in the United States. Sipp D Perspect Biol Med; 2018; 61(1):25-41. PubMed ID: 29805146 [TBL] [Abstract][Full Text] [Related]
20. Identity and ownership issues in the regulation of autologous cells. Sipp D Regen Med; 2017 Oct; 12(7):827-838. PubMed ID: 29115180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]